tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kostas Biliouris, 76 are a BUY (74.51%), 26 are a HOLD (25.49%).
Analyst Kostas Biliouris, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 34.31% that have a potential upside of 38.33% achieved within 121 days. Previously, Kostas Biliouris worked at BMO.
Kostas Biliouris’s has documented 211 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KRRO, Frequency Therapeutics at 28-Jan-2026.
Analyst best performing recommendations are on BEAM (BEAM THERAPEUTICS ).
The best stock recommendation documented was for BEAM (BEAM THERAPEUTICS ) at 7/18/2022. The price target of $61 was fulfilled within 1 day with a profit of $2.99 (5.15%) receiving and performance score of 51.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2023
$28
$0.08 (0.29%)
$30
1 months 8 days ago
(07-Jan-2026)
4/4 (100%)
$-0.93 (-3.21%)
133
Buy Since 23-Jul-2024
$80
$52.08 (186.53%)
$80
4 months 5 days ago
(10-Oct-2025)
0/9 (0%)
$53.68 (203.95%)
Buy Since 12-Mar-2025
5 months 27 days ago
(19-Aug-2025)
1/10 (10%)
$12.38 (46.51%)
118
Hold Since 10-Aug-2022
$21
$-6.92 (-24.79%)
$25
6 months 9 days ago
(06-Aug-2025)
11/11 (100%)
$2.7 (14.75%)
145
Buy Since 05-Jan-2022
$55
$27.08 (96.99%)
$78
9 months 8 days ago
(07-May-2025)
0/4 (0%)
$38.77 (238.88%)
Which stock is Kostas Biliouris is most bullish on?
Which stock is Kostas Biliouris is most reserved on?
What Year was the first public recommendation made by Kostas Biliouris?
